BCR-ABL1-like acute lymphoblastic leukemia in childhood and targeted therapy
Haematologica
.
2020 Sep 1;105(9):2200-2204.
doi: 10.3324/haematol.2018.207019.
Authors
Gunnar Cario
1
,
Veronica Leoni
2
,
Valentino Conter
2
,
André Baruchel
3
,
Martin Schrappe
1
,
Andrea Biondi
2
Affiliations
1
University Medical Center Schleswig-Holstein, Christian-Albrechts-University, Kiel, Germany.
2
Dept. of Pediatrics, University of Milano-Bicocca, FondazioneMBBM/Ospedale San Gerardo, Monza, Italy.
3
Hôpital Universitaire Robert Debré, (APHP), Université de Paris, Paris, France.
PMID:
33054045
PMCID:
PMC7556506
DOI:
10.3324/haematol.2018.207019
No abstract available
MeSH terms
Child
Fusion Proteins, bcr-abl / genetics
Humans
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / genetics
Substances
Fusion Proteins, bcr-abl